CRCAM DU LANGUEDOC (CRLA.PA) Fundamental Analysis & Valuation

EPA:CRLA • FR0010461053

Current stock price

85.42 EUR
-3.08 (-3.48%)
Last:

This CRLA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CRLA.PA Profitability Analysis

1.1 Basic Checks

  • In the past year CRLA was profitable.
  • CRLA had a negative operating cash flow in the past year.
  • In the past 5 years CRLA has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CRLA reported negative operating cash flow in multiple years.
CRLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCRLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • CRLA has a worse Return On Assets (0.51%) than 68.32% of its industry peers.
  • With a Return On Equity value of 3.23%, CRLA is not doing good in the industry: 79.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.51%
ROE 3.23%
ROIC N/A
ROA(3y)0.53%
ROA(5y)0.53%
ROE(3y)3.75%
ROE(5y)3.8%
ROIC(3y)N/A
ROIC(5y)N/A
CRLA.PA Yearly ROA, ROE, ROICCRLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

1.3 Margins

  • The Profit Margin of CRLA (25.59%) is better than 61.39% of its industry peers.
  • CRLA's Profit Margin has declined in the last couple of years.
  • CRLA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 25.59%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.9%
PM growth 5Y-3.43%
GM growth 3YN/A
GM growth 5YN/A
CRLA.PA Yearly Profit, Operating, Gross MarginsCRLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CRLA.PA Health Analysis

2.1 Basic Checks

  • CRLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CRLA has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CRLA has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CRLA has a worse debt to assets ratio.
CRLA.PA Yearly Shares OutstandingCRLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CRLA.PA Yearly Total Debt VS Total AssetsCRLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • A Debt/Equity ratio of 0.02 indicates that CRLA is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.02, CRLA belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.32%
CRLA.PA Yearly LT Debt VS Equity VS FCFCRLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRLA.PA Yearly Current Assets VS Current LiabilitesCRLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CRLA.PA Growth Analysis

3.1 Past

  • The earnings per share for CRLA have decreased by -1.24% in the last year.
  • Measured over the past years, CRLA shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.36% on average per year.
  • CRLA shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.96%.
  • The Revenue has been growing slightly by 2.09% on average over the past years.
EPS 1Y (TTM)-1.24%
EPS 3Y-6.33%
EPS 5Y-1.36%
EPS Q2Q%N/A
Revenue 1Y (TTM)46.96%
Revenue growth 3Y0.57%
Revenue growth 5Y2.09%
Sales Q2Q%102.97%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRLA.PA Yearly Revenue VS EstimatesCRLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

Find the best growth stocksShow best growing peers

2

4. CRLA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • CRLA is valuated reasonably with a Price/Earnings ratio of 9.74.
  • 74.26% of the companies in the same industry are more expensive than CRLA, based on the Price/Earnings ratio.
  • CRLA is valuated cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.74
Fwd PE N/A
CRLA.PA Price Earnings VS Forward Price EarningsCRLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRLA.PA Per share dataCRLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1K 2K 3K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CRLA.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.15%, CRLA has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 4.51, CRLA is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.80, CRLA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.15%

5.2 History

  • The dividend of CRLA has a limited annual growth rate of 2.79%.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years1
CRLA.PA Yearly Dividends per shareCRLA.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CRLA.PA Yearly Income VS Free CF VS DividendCRLA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

More info and screens

Find the best dividend stocksShow peers with best dividend

CRLA.PA Fundamentals: All Metrics, Ratios and Statistics

CRCAM DU LANGUEDOC

EPA:CRLA (4/30/2026, 7:00:00 PM)

85.42

-3.08 (-3.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Industry Strength91.89
Industry Growth56.67
Earnings (Last)04-28
Earnings (Next)07-29
Inst Owners7.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap153.76M
Revenue(TTM)1.05B
Net Income(TTM)184.24M
Analysts78.18
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.15%
Yearly DividendN/A
Dividend Growth(5Y)2.79%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.74
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)8.77
EY10.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-182.04
FCFYN/A
OCF(TTM)-179.3
OCFYN/A
SpS399.94
BVpS3173.82
TBVpS3173.82
PEG (NY)N/A
PEG (5Y)N/A
Graham Number791.375 (826.45%)
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 3.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.59%
GM N/A
FCFM N/A
ROA(3y)0.53%
ROA(5y)0.53%
ROE(3y)3.75%
ROE(5y)3.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.9%
PM growth 5Y-3.43%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)97.89%
Cap/Depr(5y)99.63%
Cap/Sales(3y)2.1%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.24%
EPS 3Y-6.33%
EPS 5Y-1.36%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.96%
Revenue growth 3Y0.57%
Revenue growth 5Y2.09%
Sales Q2Q%102.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.88%
OCF growth 3YN/A
OCF growth 5YN/A

CRCAM DU LANGUEDOC / CRLA.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CRCAM DU LANGUEDOC?

ChartMill assigns a fundamental rating of 2 / 10 to CRLA.PA.


What is the valuation status for CRLA stock?

ChartMill assigns a valuation rating of 2 / 10 to CRCAM DU LANGUEDOC (CRLA.PA). This can be considered as Overvalued.


How profitable is CRCAM DU LANGUEDOC (CRLA.PA) stock?

CRCAM DU LANGUEDOC (CRLA.PA) has a profitability rating of 2 / 10.


How financially healthy is CRCAM DU LANGUEDOC?

The financial health rating of CRCAM DU LANGUEDOC (CRLA.PA) is 2 / 10.


Can you provide the dividend sustainability for CRLA stock?

The dividend rating of CRCAM DU LANGUEDOC (CRLA.PA) is 3 / 10 and the dividend payout ratio is 0%.